Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2026-04-05 @ 2:16 AM
Study NCT ID:
NCT02115204
Status:
COMPLETED
Last Update Posted:
2019-10-03
First Post:
2014-04-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF
Sponsor:
West German Study Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2000-06
Start Date Type:
None
Primary Completion Date:
2005-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-08
First Submit QC Date:
None
Study First Post Date:
2014-04-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-30
Last Update Post Date:
2019-10-03
Last Update Post Date Type:
ACTUAL